Seeking Alpha

Alphabet: Investing In This Longevity Leader; Could AI Double The Human Lifespan?

AI and quantum computing will accelerate medical breakthroughs, potentially doubling human lifespan and revolutionizing disease treatment. Alphabet is uniquely positioned to lead in healthspan and ...
Benzinga.com

Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'

Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Isomorphic Labs says its first artificial-intelligence-designed medicines are nearly ready for human testing. What Happened: Isomorphic Labs President ...
Yahoo

Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...
ETF Daily News

Alphabet Inc. (NASDAQ:GOOGL) Position Trimmed by Human Investing LLC

Human Investing LLC decreased its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,506 shares of the ...
AOL

Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...